Despite the superiority of robotic-assisted thoracic surgery (RATS) over video-assisted thoracic surgery (VATS) for mediastinal masses, in this issue of the Journal, Alushani and colleagues 1 confirm the broad availability of VATS in most of the developing world, owing to the higher costs and inconsistent accessibility of RATS.